British Journal of Haematology · 2023 · 14 citations · 25 references
MedicineObstetricsOncologyHematologic OncologyMaternal-fetal MedicineObstetric ComplicationsMaternal Medical Complications In PregnancyPregnancyPrenatal CareDiagnosis During PregnancyNeonatal Outcomes AssessmentPrimary Cutaneous Diffuse Large B-cell Lymphoma, Leg TypePrimary Mediastinal Large B-cell LymphomaPrimary Mediastinal LymphomaRetrospective Case Study
Lymphoma in pregnancy (LIP) presents unique clinical, social and ethical challenges; however, the evidence regarding this clinical scenario is limited. We conducted a multicentre retrospective observational study reporting on the features, management, and outcomes of LIP in patients diagnosed between January 2009 and December 2020 at 16 sites in Australia and New Zealand for the first time. We included diagnoses occurring either during pregnancy or within the first 12 months following delivery. A total of 73 patients were included, 41 diagnosed antenatally (AN cohort) and 32 postnatally (PN cohort). The most common diagnoses were Hodgkin lymphoma (HL; 40 patients), diffuse large B-cell lymphoma (DLBCL; 11) and primary mediastinal B-cell lymphoma (PMBCL; six). At a median follow up of 2.37 years, the 2- and 5-year overall survival (OS) for patients with HL were 91% and 82%. For the combined DLBCL and PMBCL group, the 2-year OS was 92%. Standard curative chemotherapy regimens were successfully delivered to 64% of women in the AN cohort; however, counselling regarding future fertility and termination of pregnancy were suboptimal, and a standardised approach to staging lacking. Neonatal outcomes were generally favourable. We present a large multicentre cohort of LIP reflecting contemporary practice and identify areas in need of ongoing research.
25
Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt et al. · Journal of Clinical Oncology · 2010 · 585 citations · Full text
Medicine, Immunology, Oncology +13